← Open Payments lookup

PAUL DI FLAURO: Open Payments

NPI 1114400959 · PASADENA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,360 in 47 payments from 20 companies in 2025. Trend: 2023 $1,008 · 2024 $1,108 · 2025 $1,360

Food & beverage: $1,160Education: $200
CompanyPaymentsAmount
BeOne Medicines USA, Inc.9$199
ABBVIE INC.5$182
Novartis Pharmaceuticals Corporation7$143
Amgen Inc.1$125
Stemline Therapeutics Inc.1$124
Astellas Pharma US Inc1$100
AstraZeneca Pharmaceuticals LP5$95
Daiichi Sankyo Inc.4$83
BeiGene USA, Inc.2$64
Janssen Biotech, Inc.2$38

Products named: BRUKINSA, SCEMBLIX, KYPROLIS, ELZONRIS, IMBRUVICA, CALQUENCE, Vanflyta, VENCLEXTA.

Industry payments across CA — which companies pay providers there.